What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to update investors on the status of litigation surrounding Becton, Dickinson and Company's (BDX) proposed acquisition of CareFusion Corporation, specifically announcing a memorandum of understanding to settle related shareholder class action lawsuits.

Will the settlement affect the price or terms of the BDX-CareFusion merger?

No, the memorandum of understanding to settle the lawsuits explicitly states that the proposed settlement will not affect the amount of merger consideration that CareFusion stockholders are entitled to receive or the timing of the special meeting of CareFusion's stockholders.

What are the main allegations in the lawsuits being settled?

The lawsuits generally allege that the members of CareFusion's board of directors breached their fiduciary duties in connection with the merger by failing to ensure adequate and fair consideration for CareFusion stockholders. They also allege that CareFusion, BDX, and Merger Corp aided and abetted these breaches. The plaintiffs sought to enjoin the merger, obtain rescission, or receive rescissory damages.

What additional information is provided in this filing beyond the settlement update?

This filing also provides supplemental disclosures that expand on the background of the merger negotiations, clarify the roles of financial advisors, and present updated financial analyses and prospective financial information for CareFusion, as performed by its financial advisor, Perella Weinberg.

BDX 8-K SEC Disclosure

Summary

This Form 8-K filing by Becton, Dickinson and Company (BDX) on January 5, 2015, primarily serves to disclose an update regarding litigation surrounding its proposed acquisition of CareFusion Corporation. BD announced an Agreement and Plan of Merger with CareFusion on October 5, 2014. Subsequently, multiple shareholder class action lawsuits were filed in Delaware and California, alleging that CareFusion's board breached fiduciary duties in the merger process and that BD aided and abetted these breaches. The most significant development reported is the memorandum of understanding reached on December 31, 2014, to settle the Delaware actions. This settlement, if approved by the court, would release claims related to the merger and its disclosures, with the notable exception of appraisal rights. Crucially, the settlement does not alter the merger consideration or the timing of the CareFusion stockholder meeting. The filing also provides supplemental disclosures related to the merger's background and the financial advisor's opinions.

Key Highlights

1Becton, Dickinson and Company (BDX) has entered into a memorandum of understanding to settle shareholder class action lawsuits related to its proposed acquisition of CareFusion Corporation.
2The settlement, if approved by the Delaware Court of Chancery, would resolve litigation concerning alleged breaches of fiduciary duty by CareFusion's board and aiding and abetting by BDX in the merger process.
3The settlement will not impact the agreed-upon merger consideration for CareFusion stockholders or the scheduled date of the CareFusion stockholder meeting.
4The filing includes supplemental disclosures that clarify the background of the merger negotiations and provide additional details regarding the financial advisory services and analyses conducted by Perella Weinberg.
5Supplemental information clarifies that neither Morgan Stanley nor Barclays advised CareFusion on the negotiation or evaluation of the merger agreement with BD.
6Detailed financial analyses from CareFusion's financial advisor, Perella Weinberg, including discounted cash flow and comparable company analyses for both CareFusion and BDX, are updated.
7Prospective financial information for CareFusion, under two management cases (Management Case 1 and Management Case 2), is provided for fiscal years 2015 through 2024.

BECTON DICKINSON & CO 8-K Report, Corporate Update (Jan 5, 2015)

Summary

Key Highlights

Frequently Asked Questions